CanWalk: A feasibility study with embedded randomised controlled trial pilot of a walking intervention for people with recurrent or metastatic cancer

BMJ Open

Volumn 7, Issue 2, 2017, Pages

  Tsianakas, Vicki ^a   Harris, Jenny ^a   Ream, Emma ^b   Van Hemelrijck, Mieke ^a   Purushotham, Arnie ^c   Mucci, Lorelei ^d   Green, James S A ^e,f   Fewster, Jacquetta ^g   Armes, Jo ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e WHIPPS CROSS UNIVERSITY HOSPITAL   (United Kingdom)

^f LONDON SOUTH BANK UNIVERSITY   (United Kingdom)

^g MACMILLAN CANCER SUPPORT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; ADVERSE OUTCOME; AGED; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FATIGUE; FEASIBILITY STUDY; FEMALE; FEMALE GENITAL TRACT CANCER; HEMATOLOGIC MALIGNANCY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT-REPORTED OUTCOME; PHYSICAL ACTIVITY; PROSTATE CANCER; QUALITATIVE ANALYSIS; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; WALKING; AFFECT; BREAST TUMOR; CLINICAL TRIAL; COMPLICATION; FEMALE GENITAL TRACT TUMOR; HEMATOLOGIC DISEASE; MIDDLE AGED; NEOPLASM; PATHOLOGY; PATIENT COMPLIANCE; PATIENT SELECTION; PILOT STUDY; PROSTATE TUMOR; SELF CONCEPT; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AFFECT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FATIGUE; FEASIBILITY STUDIES; FEMALE; GENITAL NEOPLASMS, FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; PATIENT COMPLIANCE; PATIENT REPORTED OUTCOME MEASURES; PATIENT SELECTION; PILOT PROJECTS; PROSTATIC NEOPLASMS; QUALITY OF LIFE; SELF EFFICACY; WALKING;

EID: 85013032124     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-013719     Document Type: Article

References (35)

1. Mehnert A, Brähler E, Faller H, et al. Four-week prevalence of mental disorders in patients with cancer across major tumor entities. J Clin Oncol 2014;32:3540-6.
2. National Cancer Intelligence Network: recurrent and metastatic breast cancer. Data collection project. Pilot report. 2012. http://www. ncin.org.uk/view?rid=1043 (accessed 27 Jun 2016).
3. Cramarossa G, Chow E, Zhang L, et al. Predictive factors for overall quality of life in patients with advanced cancer. Support Care Cancer 2013;21:1709-16.
4. Javaheri PA, Nekolaichuk C, Haennel R, et al. Feasibility of a pedometer-based walking program for survivors of breast and head and neck cancer undergoing radiation therapy. Physiother Can 2015;62:205-13.
5. Lowe SS, Watanabe SM, Courneya KS. Physical activity as a supportive care intervention in palliative cancer patients: a systematic review. J Support Oncol 2009;7:27-34.
6. Beaton R, Pagdin-Friesen W, Robertson C, et al. Effects of exercise intervention on persons with metastatic cancer: a systematic review. Physiother Can 2009;61:141-53.
7. Lowe SS, Watanabe SM, Baracos VE, et al. Physical activity interests and preferences in palliative cancer patients. Support Care Cancer 2010;18:1469-75.
8. Ogilvie D, Foster CE, Rothnie H, et al. Interventions to promote walking: systematic review. Br Med J 2007;334:1204.
9. Chen HM, Tsai CM, Wu YC, et al. Randomised controlled trial on the effectiveness of home-based walking exercise on anxiety, depression and cancer-related symptoms in patients with lung cancer. Br J Cancer 2015;112:438-45.
10. Hillsdon M, Thorogood M, White I, et al. Advising people to take more exercise is ineffective: a randomized controlled trial of physical activity promotion in primary care. Int J Epidemiol 2002;31:808-15.
11. Harris J, Tsianakas V, Ream E, et al. CanWalk: study protocol for a randomized feasibility trial of a walking intervention for people with recurrent or metastatic cancer. Pilot Feasibility Stud 2015;1:7.
12. Bryman A. Integrating quantitative and qualitative research: how is it done? Qual Res 2006;6:97-113.
13. Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat 2005;4:287-91.
14. Sim J, Lewis M. The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency. J Clin Epidemiol 2012;65:301-8.
15. National Institute for Healthcare and Clinical Excellence (NICE). Physical activity, 2012. https://www.nice.org.uk/advice/lgb3/chapter/Introduction (accessed 27 Jun 2016).
16. National Institute for Healthcare and Clinical Excellence (NICE). Behaviour change: individual approaches, 2014. https://www.nice. org.uk/guidance/PH49 (accessed 27 Jun 2016).
17. Macmillan: move more, 2011. https://be.macmillan.org.uk/be/p-19569-move-more-your-complete-guide-to-becoming-more-active. aspx (accessed 27 Jun 2016).
18. The Ramblers: walking for health, 2015. https://www. walkingforhealth.org.uk/(accessed 27 Jun 2016).
19. Rollnick S, Butler CC, Kinnersley P, et al. Competent novice: motivational interviewing. BMJ 2010;340:1242-5.
20. Ritchie J, Spencer LS. Qualitative data analysis for applied policy research. London Routledge, 2014;173-94.
21. Bugge C, Williams B, Hagen S, et al. A process for decision-making after pilot and feasibility trials (adept): Development following a feasibility study of a complex intervention for pelvic organ prolapse. Trials 2013;14:353.
22. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993;11:570-9.
23. Mendoza TWX, Cleeland CS, Morrissey M, et al. Brief Fatigue Inventory, 2016. http://www.mdanderson.org/education-andresearch/departments-programs-and-labs/departments-anddivisions/symptom-research/symptom-assessment-tools/brief-fatigue-inventory-bfi.html (accessed 27 Jun 2016).
24. Kroll T, Kehn M, Ho PS, et al. The SCI exercise self-efficacy scale (ESES): development and psychometric properties. Int J Behav Nutr Phys Act 2007;4:34.
25. Lovibond S, Lovibond PF. Manual for the depression anxiety stress scales. Psychology Foundation of Australia, 1996.
26. NHS England Research Foundation: EQ-5D, 2016. http://www. euroqol.org/about-eq-5d.html (accessed 27 Jun 2016).
27. Public Health England. The General Practice Physical Activity Questionnaire (GPPAQ), 2009. http://www.erpho.org.uk/viewResource.aspx?id=18813 (accessed 27 Jun 2016).
28. National Institute for Healthcare and Clinical Excellence [NICE]. Walking and cycling, 2013. https://www.nice.org.uk/advice/lgb8 (accessed 27 Jun 2016).
29. Bowen DJ, Kreuter M, Spring B, et al. How we design feasibility studies. Am J Prev Med 2009;36:452-7.
30. Rummans TA, Clark MM, Sloan JA, et al. Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: a randomized controlled trial. J Clin Oncol 2006;24:635-42.
31. Campbell A, Mutrie N, White F, et al. A pilot study of a supervised group exercise programme as a rehabilitation treatment for women with breast cancer receiving adjuvant treatment. Eur J Oncol Nurs 2005;9:56-63.
32. Courneya KS, Friedenreich CM, Quinney HA, et al. A randomized trial of exercise and quality of life in colorectal cancer survivors. Eur J Cancer Care 2003;12:347-57.
33. MacMillan F, Kirk A. Patterns of physical activity and the effect of accelerometer wear on physical activity participation in people with Type 2 diabetes. CARE 2010;3:6-22.
34. Broadhead WE, Gehlbach SH, de Gruy FV, et al. The Duke-UNC functional social support questionnaire. Measurement of social support in family medicine patients. Med Care 1988;26:709-23.
35. Freedson P, Bowles HR, Troiano R, et al. Assessment of physical activity using wearable monitors: recommendations for monitor calibration and use in the field. Med Sci Sports Exerc 2012;44:S1-4.